<?xml version="1.0" encoding="UTF-8"?>
<p>Combinations of other drugs with CQ are also being investigated in ongoing clinical trials. FBV tablets combined with CQ phosphate in the treatment of coronavirus pneumonia is being investigated in the ChiCTR2000030987 clinical trial. In ChiCTR2000029609, the efficacy of CQ alone, LPV/RTV alone and CQ plus LPV/RTV is being investigated in mild and severe patients [
 <xref rid="B103" ref-type="bibr">103</xref>]. Two or more drug combinations with CQ are also being investigated in other countries. For example, in THDMS-COVID19, oseltamivir 300 mg per day plus CQ 1000 mg per day or darunavir 400 mg every 8 h RTV 2.5 mg/kg plus oseltamivir 4–6 mg/kg plus CQ 500 mg are being studied [
 <xref rid="B105" ref-type="bibr">105</xref>].
</p>
